ABL Lyon


About us

ABL Lyon offers its expertise for the evaluation of immunotherapies


Immune Checkpoints, Immune Response, Immunophenotyping

Business offer

What do all immunotherapies under development have in common?
Whether in preclinical or clinical stage, they all need robust and reliable monitoring tools to track and characterize the immune response.
Monitoring the immune response in a regulatory compliant setting is our expertise at ABL. We support dozens of preclinical and clinical studies to evaluate the safety and efficacy of monoclonal antibodies (mAbs), immune-checkpoint inhibitors ,vaccines, Antibody Drug Conjugates (ADCs), Chimeric Antigen Receptor T cells (CAR-T cells) and several other candidate immunotherapies.

Field of application
  • antibodies
  • cellular immunotherapy
  • immunomodulators
  • vaccins
  • biomarkers
Therapeutic application
  • hematology
  • infectiology
  • immunology
  • Neurobiology


  • Expression and pathway analysis of target
  • quantification of target
  • Assay development in in-vitro & in-vivo models
  • Research exploratory companion biomarkers
  • Phase I
  • Phase II
  • Phase III
  • Phase IV


  • Service
  • Technology Supplier